Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens

被引:22
作者
Boyko, Vitaly
Leavitt, Maria
Gorelick, Robert
Fu, William
Nikolaitchik, Olga
Pathak, Vinay K.
Nagashima, Kunio
Hu, Wei-Shau [1 ]
机构
[1] SAIC Frederick Inc, HIV Drug Resistance Program, NCI, Frederick, MD 21702 USA
[2] SAIC Frederick Inc, AIDS Vaccine Program, Basic Res Program, NCI, Frederick, MD 21702 USA
[3] SAIC Frederick Inc, Image Anal Lab, NCI, Frederick, MD 21702 USA
关键词
D O I
10.1016/j.molcel.2006.05.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Approximately one million people in the world are dually infected with both HIV-1 and HIV-2. To identity potential interactions between these two human pathogens, we examined whether HIV-1 and HIV-2 Gag proteins can coassemble and functionally complement each other. We generated HIV-1 - and HIV-2-based vectors with mutations in Gag; compared with wild-type vectors, these mutants had drastically decreased viral titers. Coexpression of the mutant HIV-1 and HIV-2 Gag could generate infectious viruses; furthermore, heterologous complementation in certain combinations showed efficiency similar to homologous complementation. Additionally, we used bimolecularfluorescence complementation analysis to directly demonstrate that HIV-1 and HIV-2 Gag can interact and coassemble. Taken together, our results indicate that HIV-1 and HIV-2 Gag polyproteins can coassemble and functionally complement each other during virus replication; to our knowledge, this is the first demonstration of its kind. These studies have important implications for AIDS treatment and the evolution of primate lentiviruses.
引用
收藏
页码:281 / 287
页数:7
相关论文
共 26 条
[1]   The retroviral capsid domain dictates virion size, morphology, and coassembly of Gag into virus-like particles [J].
Ako-Adjei, D ;
Johnson, MC ;
Vogt, VM .
JOURNAL OF VIROLOGY, 2005, 79 (21) :13463-13472
[2]   The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates [J].
Ariën, KK ;
Abraha, A ;
Quiñones-Mateu, ME ;
Kestens, L ;
Vanham, G ;
Arts, EJ .
JOURNAL OF VIROLOGY, 2005, 79 (14) :8979-8990
[3]   Hybrid origin of SIV in chimpanzees [J].
Bailes, E ;
Gao, F ;
Bibollet-Ruche, F ;
Courgnaud, V ;
Peeters, M ;
Marx, PA ;
Hahn, BH ;
Sharp, PM .
SCIENCE, 2003, 300 (5626) :1713-1713
[4]   Conditions for copackaging Rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding [J].
Bennett, RP ;
Wills, JW .
JOURNAL OF VIROLOGY, 1999, 73 (03) :2045-2051
[5]   HIV CAUSES AIDS [J].
BLATTNER, W ;
GALLO, RC ;
TEMIN, HM .
SCIENCE, 1988, 241 (4865) :515-515
[6]   Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 Tat activation-response RNA decoy [J].
Browning, CM ;
Cagnon, L ;
Good, PD ;
Rossi, J ;
Engelke, DR ;
Markovitz, DM .
JOURNAL OF VIROLOGY, 1999, 73 (06) :5191-5195
[7]   Human immunodeficiency virus type 1 nucleocapsid Zn2+ fingers are required for efficient reverse transcription, initial integration processes, an protection of newly synthesized viral DNA [J].
Buckman, JS ;
Bosche, WJ ;
Gorelick, RJ .
JOURNAL OF VIROLOGY, 2003, 77 (02) :1469-1480
[8]   Identification of a major restriction in HIV-1 intersubtype recombination [J].
Chin, MPS ;
Rhodes, TD ;
Chen, JB ;
Fu, W ;
Hu, WS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (25) :9002-9007
[9]  
CLAVEL F, 1987, AIDS, V1, P135
[10]  
Curlin ME, 2004, AIDS RES HUM RETROV, V20, P958, DOI 10.1089/aid.2004.20.958